Laurent Fischer

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Redwood City, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Judit Ryvkin, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Laurent Fischer

Form 4 holding Director

AtaiBeckley Inc.

Security class
Stock Option
Shares / value
121,968
Estimated value
Report date
04 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CEO, PRESIDENT AND DIRECTOR, Director

Adverum Biotechnologies, Inc.

Security class
Common Stock - Performance Stock Units
Shares / value
0
Estimated value
Report date
09 Dec 2025
Price
Ownership
Direct
Form 4 holding CEO, PRESIDENT AND DIRECTOR, Director

Adverum Biotechnologies, Inc.

Security class
Common Stock - Restricted Stock Units
Shares / value
0
Estimated value
Report date
09 Dec 2025
Price
Ownership
Direct
Form 4 holding Director

CTI BIOPHARMA CORP

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
26 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Laurent Fischer

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .